Huang Xin-yu, Wang Hong-cheng, Yuan Zhou, Huang Jian, Zheng Qi
Department of Surgery, Shanghai Jiaotong University, Shanghai, China.
Hepatogastroenterology. 2012 May;59(115):889-93. doi: 10.5754/hge11476.
BACKGROUND/AIMS: There is growing evidence that chronic stress is associated with cancer pathogenesis and progression, but the mechanisms involved in this association are poorly understood. This study aims to examine the effect of stress hormone norepinephrine (NE) on proliferation, migration and invasion of human pancreatic cancer cells and the molecular pathway involved.
PANC-1 cells were examined for the expression of β-Adrenergic receptor (β-AR) subtypes, β1-AR, β2-AR by RT-PCR and western blotting, respectively. The PANC-1 cells proliferation, cell cycle distribution, cell migration and invasion were assessed by CCK-8, flow cytometry, scratch wound healing and transwell Matrigel, respectively.
PANC- 1 cells expressed both β1-AR and β2-AR protein. Exposure of PANC-1 cells to increasing concentrations of NE stimulated cell proliferation in a dose-dependent fashion. In addition, NE increased S-phase population and decreased G1 and G2-phase population of PANC- 1 cells. Furthermore, NE significantly enhanced migration and invasion of PANC-1 cells. More strikingly, we observed that NE elevated P38/MAPK phosphorylation (Phos-p38) level. These stimulatory effects were completely abolished by β-AR antagonist propranolol (PRO) or P38/MAPK inhibitor SB203580.
NE could stimulate pancreatic cancer cell proliferation, migration and invasion through a β-AR-dependent activation of P38/MAPK pathway involved.
背景/目的:越来越多的证据表明,慢性应激与癌症的发生和发展相关,但这种关联所涉及的机制尚不清楚。本研究旨在探讨应激激素去甲肾上腺素(NE)对人胰腺癌细胞增殖、迁移和侵袭的影响及其涉及的分子途径。
分别采用逆转录聚合酶链反应(RT-PCR)和蛋白质印迹法检测PANC-1细胞中β-肾上腺素能受体(β-AR)亚型β1-AR、β2-AR的表达。分别采用CCK-8法、流式细胞术、划痕伤口愈合实验和基质胶Transwell实验评估PANC-1细胞的增殖、细胞周期分布、细胞迁移和侵袭能力。
PANC-1细胞同时表达β1-AR和β2-AR蛋白。将PANC-1细胞暴露于浓度递增的NE中,可呈剂量依赖性刺激细胞增殖。此外,NE增加了PANC-1细胞的S期细胞比例,降低了G1期和G2期细胞比例。此外,NE显著增强了PANC-1细胞的迁移和侵袭能力。更显著的是,我们观察到NE提高了P38/丝裂原活化蛋白激酶(MAPK)的磷酸化(Phos-p38)水平。β-AR拮抗剂普萘洛尔(PRO)或P38/MAPK抑制剂SB203580可完全消除这些刺激作用。
NE可通过β-AR依赖的P38/MAPK途径激活,刺激胰腺癌细胞的增殖、迁移和侵袭。